Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00XMP
|
||||
| Former ID |
DNC005844
|
||||
| Drug Name |
1-Methyl-4-(1-phenyl-ethyl)-piperazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H20N2
|
||||
| Canonical SMILES |
CC(C1=CC=CC=C1)N2CCN(CC2)C
|
||||
| InChI |
1S/C13H20N2/c1-12(13-6-4-3-5-7-13)15-10-8-14(2)9-11-15/h3-7,12H,8-11H2,1-2H3
|
||||
| InChIKey |
CQTKDGNXBCFBTR-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Melanocortin-4 receptor | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
| Reactome | Peptide ligand-binding receptors | ||||
| G alpha (s) signalling events | |||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
| Peptide GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2005 Nov 15;15(22):4973-8.Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.